Showing results (661-670 of 1,904) with videos related to
Sort By:
Pageof 191
Current Neuropharmacology|March 10, 2018
Closed-loop Neuropharmacology for Epilepsy: Distant Dream or Future Reality?Irene Aicua-Rapun, Pascal André, Jan NovyCurrent Neuropharmacology|November 6, 2019
Targeting the Neuronal Activity of Prefrontal Cortex: New Directions for the Therapy of DepressionXiao-Ting Zhou, Wen-Dai Bao, Dan Liu, et al.Current Neuropharmacology|August 24, 2017
In Silico Studies in Drug Research Against Neurodegenerative DiseasesFarahnaz Rezaei Makhouri, Jahan B GhasemiCurrent Neuropharmacology|August 30, 2017
Therapeutic Strategies for Treatment of Inflammation-related DepressionMiroslav Adzic, Zeljka Brkic, Milos Mitic, et al.Current Neuropharmacology|May 25, 2022
Effect of Repetitive Transcranial Magnetic Stimulation in Inducing Weight Loss in Patients with Chronic Schizophrenia: A Randomized, Double-Blind Controlled 4-Week StudyXiuru Su, Xuan Wang, Xiuling Pan, et al.Current Neuropharmacology|May 27, 2022
Optimization of Therapy in Patients with Epilepsy and Psychiatric Comorbidities: Key PointsFrancesco Pisani, Laura Rosa Pisani, Maria Antonietta Barbieri, et al.Current Neuropharmacology|June 30, 2021
SARS-Cov-2 Damage on the Nervous System and Mental HealthMohamed Said Boulkrane, Victoria Ilina, Roman Melchakov, et al.Current Neuropharmacology|March 3, 2020
The e-Psychonauts' 'Spiced' World; Assessment of the Synthetic Cannabinoids' Information Available OnlineCaroline Zangani, Fabrizio Schifano, Flavia Napoletano, et al.Current Neuropharmacology|March 4, 2020
Role of Grina/Nmdara1 in the Central Nervous System DiseasesKai Chen, Liu Nan Yang, Chuan Lai, et al.Current Neuropharmacology|January 7, 2020
Underlying Mechanisms and Potential Therapeutic Molecular Targets in Blood-Brain Barrier Disruption after Subarachnoid HemorrhageYuchen Li, Pei Wu, Ji C Bihl, et al.Pageof 191